Our Pricing

Where to Inject Mounjaro: UK Clinical Guidance on Injection Sites

Understanding where to inject Mounjaro UK patients can safely administer their weekly tirzepatide dose is essential for treatment success. Mounjaro can be injected subcutaneously into three approved sites: the abdomen, thigh, or upper arm, with proper rotation reducing injection site reactions and optimising absorption. Our UK-registered clinical team provides comprehensive guidance on injection technique to support your weight management journey.

Approved Mounjaro Injection Sites in the UK

Mounjaro (tirzepatide) is licensed by the MHRA for subcutaneous injection into three specific body areas: the abdomen (excluding a 5cm radius around the navel), the front and outer thigh, or the back of the upper arm [1]. These sites contain adequate subcutaneous fatty tissue for optimal medication absorption whilst minimising discomfort.

The abdomen is the most commonly recommended site for where to inject Mounjaro, as it typically offers the most consistent absorption rates and the largest injection area for proper rotation [1]. Clinical trials including SURPASS-1 through SURPASS-5 used predominantly abdominal injections, achieving average weight reductions of up to 22.5% over 72 weeks in participants receiving the 15mg maintenance dose [2].

The thigh provides an accessible alternative site, particularly for patients who prefer self-administration without assistance. The upper arm requires either a second person or specialised technique to ensure proper subcutaneous delivery, making it less practical for most patients managing their treatment independently.

How to Inject Mounjaro: Step-by-Step Technique

Proper injection technique begins with selecting a clean, dry injection site at least 5cm away from your previous injection location. Allow the Mounjaro KwikPen to reach room temperature for 30 minutes before administration, as cold medication can increase injection discomfort and affect absorption [1].

Pinch approximately 2-3cm of skin between your thumb and forefinger to create a fold of subcutaneous tissue. Insert the needle at a 90-degree angle with a swift, confident motion, then press the injection button firmly until you hear a click. Maintain pressure for 10 seconds after the click to ensure complete dose delivery — premature withdrawal may result in medication leakage and reduced efficacy [1].

After injection, dispose of the used pen in a sharps container approved for household use. Never recap needles, as this increases needlestick injury risk. UK pharmacies including Cured Pharmacy can provide guidance on obtaining appropriate sharps disposal containers through your local authority.

Common Injection Technique Mistakes

Injecting into muscle rather than subcutaneous tissue represents the most frequent technical error, often occurring when patients fail to pinch the skin adequately or use excessive force during needle insertion. Intramuscular delivery can alter tirzepatide absorption rates and increase injection site pain.

Inadequate site rotation leads to lipohypertrophy — localised fat tissue thickening that impairs medication absorption and may reduce treatment effectiveness [3]. Maintaining a detailed rotation schedule and avoiding the same injection site for at least four weeks minimises this risk whilst supporting consistent therapeutic outcomes.

Mounjaro Injection Site Rotation Schedule

Systematic site rotation prevents tissue damage and maintains optimal absorption throughout your treatment course. Divide your chosen injection area into quadrants or zones, rotating clockwise or in a predetermined pattern to ensure no site receives repeat injections within a four-week period [1].

For abdominal injections, visualise four quadrants around your navel (upper right, upper left, lower right, lower left), alternating between quadrants each week. If using multiple injection sites, consider dedicating specific weeks to each location — for example, abdomen for weeks one and two, thigh for week three, returning to abdomen for week four.

Maintaining a written or digital log of injection sites and dates helps prevent inadvertent reuse of recent locations, particularly important during the dose escalation phase when you may be adjusting to your treatment routine. Many patients find smartphone calendar reminders or dedicated diabetes management apps useful for tracking their rotation schedule.

When to Avoid Specific Injection Sites

Temporarily exclude injection sites showing signs of irritation, bruising, redness, swelling, or tenderness from your rotation schedule. These symptoms typically resolve within 3-7 days, after which the site can be reintroduced [1]. Persistent reactions lasting beyond two weeks warrant clinical review by your prescriber.

Avoid injecting through clothing, over tattoos, scars, moles, or areas with skin conditions such as eczema or psoriasis, as these factors may affect absorption and increase infection risk. Surgical scars require at least six months of healing before they become suitable injection sites.

Comparing Mounjaro Injection Sites: Abdomen vs Thigh vs Arm

Clinical pharmacokinetic studies demonstrate subtle absorption differences between injection sites, though these variations rarely affect overall treatment outcomes when proper technique is maintained [1]. Abdominal injections typically produce the most predictable absorption profiles, with peak tirzepatide concentrations occurring approximately 24-72 hours post-injection.

Thigh injections may absorb slightly more slowly than abdominal administration, potentially beneficial for patients experiencing gastrointestinal side effects during dose escalation. The increased subcutaneous tissue depth in the thigh can also make this site more comfortable for patients with lower body fat percentages.

Upper arm injections show comparable bioavailability to other sites but present practical challenges for self-administration. This site works best when a family member or caregiver can assist with weekly injections, ensuring proper technique and subcutaneous depth.

Managing Injection Site Reactions with Mounjaro

Mild injection site reactions affect approximately 2-4% of patients using tirzepatide, typically manifesting as temporary redness, slight swelling, or minor discomfort lasting less than 48 hours [2]. These reactions generally diminish in frequency and severity as treatment continues and your body adapts to the medication.

Applying a cool compress to the injection site for 5-10 minutes before and after administration can reduce discomfort and minimise visible reactions. Ensure the skin is completely dry before injecting, as moisture can increase friction during needle insertion and contribute to irritation [1].

Persistent or worsening injection site reactions — including significant swelling, warmth, increasing pain, or discharge — may indicate infection or allergic response requiring immediate clinical assessment. Contact your prescriber or NHS 111 if symptoms don't resolve within 72 hours or if you develop fever alongside injection site changes.

Reducing Injection Discomfort

Allowing Mounjaro to reach room temperature before injection significantly reduces discomfort, as cold medication stimulates more nerve endings during administration. Never use external heat sources to warm the pen — simply remove it from refrigeration 30 minutes before your scheduled injection time.

Inject slowly and steadily rather than using rapid, forceful motion. The KwikPen's design controls injection speed automatically once activated, but gentle, confident handling during insertion minimises tissue trauma and post-injection soreness. Relaxing your muscles at the injection site also reduces discomfort compared to tensing during administration.

Mounjaro Treatment at Cured Pharmacy

Cured Pharmacy supplies genuine UK-licensed Mounjaro KwikPens from £135.00, with all prescriptions issued following comprehensive clinical assessment by our UK-registered prescribers. Our online consultation takes under three minutes and covers your medical history, current medications, weight management goals, and suitability for tirzepatide therapy.

Each Mounjaro supply includes detailed patient information leaflets covering injection technique, site selection, and rotation schedules. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team remain available throughout your treatment for technique queries, side effect management, and ongoing support.

We provide discreet packaging and next-day delivery options across the UK, with transparent upfront pricing displayed before you begin your consultation. All prescription medications require clinical approval from a UK prescriber — our team will assess your individual circumstances to determine whether Mounjaro represents an appropriate treatment option for your weight management needs.

Scientific References

1. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14298
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. Frid, A. H., Kreugel, G., Grassi, G., et al. (2016). New Injection Recommendations for Patients with Diabetes. Diabetes & Metabolism, 42(Suppl 1), S3–S23. https://doi.org/10.1016/S1262-3636(16)30006-8

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.